Time saved as a demonstration of clinical meaningfulness and illustrated using the donanemab TRAILBLAZER-ALZ study findings
estimated treatment difference between semaglutide 7.2 mg and placebo, 14.8 percentage points
How to plan a GLP-1 pharmacy trip to Mexico Planning makes the difference between a smooth, cost-effective trip and a frustrating waste of time
In whats known as the SELECT trial, co-authored by UT Southwestern endocrinologist Ildiko Lingvay, M.D., M.P.H., M.S.C.S., 44% of patients using semaglutide lost more than 10% of their body weight within two years, and 11% of patients lost more than 20% more than enough to improve fertility
A few months ago, FDA officials declared the shortages were replenished, so the flexibilities given to the manufacturers of the compounded drugs are about to end